Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?Gemma Conte, Francesca Ungaro, Ersilia Fiscarelli et al.|ACS Applied Materials & Interfaces|2022Cited by 96
Hybrid Lipid/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon <i>In Vitro</i> Deposition on the Human Epithelial Airway BarrierIvana d’Angelo, Francesca Ungaro, Estelle Durantie et al.|Journal of Aerosol Medicine and Pulmonary Drug Delivery|2017Cited by 72
PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infectionGabriella Costabile, Francesca Ungaro, Vadim Makarov et al.|Nanomedicine Nanotechnology Biology and Medicine|2019Cited by 47
PEI‐Engineered Lipid@PLGA Hybrid Nanoparticles for Multimodal Delivery of Antigens and Immune Adjuvants to the Respiratory MucosaSusy Brusco, Francesca Ungaro, Annunziata Corteggio et al.|Advanced Healthcare Materials|2024Cited by 9